Key facts
- IBEX Innovations’s last known valuation is $13.1M (Apr 2025).
- It has raised $17.0M; the latest was Later Stage VC ($4.3M) in Apr 2025.
- Notable investors include Innovate UK, Mercia Ventures, European Regional Development Fund (Brandenburg), Horizon 2020, IP Group — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for IBEX Innovations
- ·The full record, as it builds
Funding rounds
No funding rounds for IBEX Innovations are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IBEX Innovations
Developer of X-ray imaging software designed specifically for medical devices. The company's technology revolutionizes osteoporosis screening and diagnosis by leveraging standard images and helps to transform into an opportunity for osteoporosis diagnosis, effectively bridging the diagnosis gap, integrating into imaging systems to automatically identify measures of bone density and computing the T-score without any user intervention, enabling healthcare providers to deliver improved medical diagnostic imaging as well as detection of impurities, defects, and threats.
- Sector
- Healthcare
- HQ
- Sedgefield, United Kingdom
- Founded
- 2010
- Employees
- 19
- Website
- ibexinnovations.co.uk/
- Ownership
- Privately Held (backing)
IBEX Innovations doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IBEX Innovations shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IBEX Innovations in its N-PORT filings yet. We sweep new filings monthly.